Punitive Damages To Proceed In Prempro Trial

Law360, New York (January 30, 2007, 12:00 AM EST) -- A day after a state jury in Philadelphia determined that Wyeth’s hormone replacement therapy Prempro caused an Arkansas woman’s breast cancer, a judge said there was insufficient evidence for the jury to find that the drug maker acted recklessly, but allowed the punitive damage phase of the trial to move forward.

The jury in the Philadelphia Court of Common Pleas on Monday ordered Wyeth to shell out $1.5 million in compensation after finding that its conduct was “malicious, wanton, willful or oppressive or showed reckless indifference...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.